AMEH:NSD-Apollo Medical Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 95.62

Change

-0.75 (-0.78)%

Market Cap

USD 4.28B

Volume

0.50M

Avg Analyst Target

USD 92.00 (-3.79%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Company Website : http://www.apollomed.net

Address : 1668 South Garfield Avenue, Alhambra, CA, United States, 91801

Employees : 630

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.56

52 Week High : 114.55

Short Ratio : 5.29

52 Week Low : 17.01

Shorted Shares : 2,201,555

200 Day Moving Average : 55.74

Shorted Shares Previous Month : 1,504,325

50 Day Moving Average : 81.41

Shares Held By Insiders : 32.26%

Short Percentage : 5.00%

Shares Held by Institutions : 19.36%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

N/A

 USD5.85B 47.80 15.75
AMED Amedisys Inc

-6.18 (-3.83%)

 USD5.27B 21.69 15.11
LHCG LHC Group Inc

-0.61 (-0.38%)

 USD5.09B 43.12 22.10
ENSG The Ensign Group Inc

-0.51 (-0.67%)

 USD4.19B 22.80 17.75
SGRY Surgery Partners Inc

-4.19 (-9.07%)

 USD3.81B 63.00 18.88
PRSC The Providence Service Corpora..

N/A

 USD2.21B 74.23 15.08
HCSG Healthcare Services Group Inc

-0.14 (-0.56%)

 USD1.86B 20.96 12.14
JYNT The Joint Corp

-3.98 (-3.76%)

 USD1.52B 90.50 122.14
AVAH Aveanna Healthcare Holdings In..

-0.11 (-1.33%)

 USD1.52B N/A 13.31
ADUS Addus HomeCare Corporation

-1.53 (-1.81%)

 USD1.35B 35.53 22.03

ETFs Containing AMEH

Symbol Name Weight Mer Price(Change) Market Cap
CSF VictoryShares US Discover.. 0.00 % 0.38 %

+0.01 (+0.01%)

 USD0.06B
EWSC Invesco Exchange-Traded F.. 0.00 % 0.40 %

+0.52 (+0.64%)

 USD0.06B
IWC iShares Micro-Cap ETF 0.00 % 0.60 %

-0.81 (-0.55%)

 USD1.28B
CSA Victory Portfolios II - V.. 0.00 % 0.35 %

N/A

 USD0.03B
TPSC Timothy Plan US Small Cap.. 0.00 % 0.52 %

+0.10 (+0.30%)

 N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 423.37% 95% A 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 423.37% 95% A 99% A+
Trailing 12 Months  
Capital Gain 467.14% 90% A- 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 467.14% 90% A- 98% A+
Trailing 5 Years  
Capital Gain 2,204.10% 83% B 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,204.10% 83% B 98% A+
Average Annual (5 Year Horizon)  
Capital Gain 67.60% 84% B 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.60% 84% B 89% B+
Risk Return Profile  
Volatility (Standard Deviation) 107.26% 32% F 15% F
Risk Adjusted Return 63.02% 58% F 78% C+
Market Capitalization 4.28B 86% B 84% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 75.47 27% F 14% F
Price/Book Ratio 9.17 23% F 15% F
Price / Cash Flow Ratio 92.80 14% F 5% F
EV/EBITDA 18.37 47% F 40% F
Management Effectiveness  
Return on Equity 23.27% 86% B 89% B+
Return on Invested Capital 3.79% 36% F 63% D
Return on Assets 7.67% 82% B- 89% B+
Debt to Equity Ratio 51.72% 35% F 37% F
Technical Ratios  
Short Ratio 5.29 32% F 31% F
Short Percent 19.63% 5% F 7% F
Beta 0.56 61% D- 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.